160 related articles for article (PubMed ID: 25791646)
21. Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.
Bassetti M; Poulakou G; Timsit JF
Intensive Care Med; 2016 Jun; 42(6):955-8. PubMed ID: 27043234
[No Abstract] [Full Text] [Related]
22. Currently available antimicrobial agents and their potential for use as monotherapy.
Peterson LR
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
[TBL] [Abstract][Full Text] [Related]
23. [The rational use of fluoroquinolones].
Zhang Y
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):7-8. PubMed ID: 12795261
[No Abstract] [Full Text] [Related]
24. [Usefulness of PK/PD parameters of antimicrobials in the treatment of complex and extremely-resistant infections].
Horcajada JP
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():16-8. PubMed ID: 26365728
[TBL] [Abstract][Full Text] [Related]
25. Information from your family doctor. When antibiotics can help.
American Academy of Family Physicians
Am Fam Physician; 2006 Sep; 74(6):969. PubMed ID: 17002030
[No Abstract] [Full Text] [Related]
26. The use of new antimicrobial agents in serious life-threatening infections--pros and cons.
Neu HC
Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():309-18. PubMed ID: 3138357
[No Abstract] [Full Text] [Related]
27. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
28. Pets and antimicrobial resistance.
Umber JK; Bender JB
Vet Clin North Am Small Anim Pract; 2009 Mar; 39(2):279-92. PubMed ID: 19185194
[TBL] [Abstract][Full Text] [Related]
29. Choice of antimicrobial drugs by the site of infection.
Chung SJ; Chung RY
Comput Methods Programs Biomed; 1987 Feb; 24(1):47-62. PubMed ID: 3103978
[TBL] [Abstract][Full Text] [Related]
30. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
Naumann P; Dopp C
Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
[No Abstract] [Full Text] [Related]
31. [Duration of antimicrobial therapy].
Pasquau J; Matesanz M
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():30-3. PubMed ID: 26365731
[TBL] [Abstract][Full Text] [Related]
32. Maintaining fluoroquinolone class efficacy: review of influencing factors.
Scheld WM
Emerg Infect Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12533274
[TBL] [Abstract][Full Text] [Related]
33. Fighting bacterial infections-future treatment options.
Fernebro J
Drug Resist Updat; 2011 Apr; 14(2):125-39. PubMed ID: 21367651
[TBL] [Abstract][Full Text] [Related]
34. An overview of antimicrobial peptides and the latest advances in their development.
Sierra JM; Fusté E; Rabanal F; Vinuesa T; Viñas M
Expert Opin Biol Ther; 2017 Jun; 17(6):663-676. PubMed ID: 28368216
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic use of fluoroquinolones].
Lumio J
Duodecim; 1999; 115(3):304-15. PubMed ID: 11830877
[No Abstract] [Full Text] [Related]
36. Joint Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Preventive Medicine, Public Health and Hygiene (SEMPSPH) for Combating Antimicrobial Resistance.
Steering Committees of the Spanish Society of Preventive Medicine, Public Health and Hygiene (SEMPSPH) and of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Enferm Infecc Microbiol Clin; 2017 Mar; 35(3):139-140. PubMed ID: 28249703
[No Abstract] [Full Text] [Related]
37. [New antibacterial agents].
Järvinen A; Valtonen V
Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883
[No Abstract] [Full Text] [Related]
38. Defensin-based anti-infective strategies.
Wilmes M; Sahl HG
Int J Med Microbiol; 2014 Jan; 304(1):93-9. PubMed ID: 24119539
[TBL] [Abstract][Full Text] [Related]
39. Potential impact of rapid diagnostic tests on improving antimicrobial use.
Tenover FC
Ann N Y Acad Sci; 2010 Dec; 1213():70-80. PubMed ID: 21054433
[TBL] [Abstract][Full Text] [Related]
40. Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms.
Tarai B; Das P; Kumar D
Indian J Med Microbiol; 2014; 32(3):353-4. PubMed ID: 25008844
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
